Tuesday 18th July 2017
Autologous lipotransfer utilises the patient’s own cells to reverse the effects of fibrosis
This pioneering and innovative new treatment option is to treat fibrosis of the face and other tissues in people with scleroderma. The technique is known as autologous lipotransfer and utilises the patient’s own cells to reconstruct facial tissue and reverse the effects of fibrosis and internal scarring.